TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 72 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $73,000 | -47.9% | 11,244 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $140,000 | -38.3% | 12,035 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $227,000 | -14.0% | 12,184 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $264,000 | +156.3% | 12,474 | +146.6% | 0.00% | – |
| Q1 2021 | $103,000 | -23.1% | 5,059 | +0.3% | 0.00% | – |
| Q4 2020 | $134,000 | – | 5,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital Investment Advisors, LLC | 10,000 | $17,700 | 0.00% |